Park Avenue Securities »

Amicus Therapeutics shares owned by Park Avenue Securities

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Park Avenue Securities from 13F filings

Historical chart of Park Avenue Securities investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Park Avenue Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Park Avenue Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $155k 13k 11.78
2023-12-31 $177k 13k 14.18
2023-09-30 $128k 11k 12.16
2022-12-31 $129k 11k 12.25

More positions owned by Park Avenue Securities

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Mbs Etf (MBB)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Hdg Msci Eafe (HEFA)

View all positions for Park Avenue Securities

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
Jpmorgan Chase & Co
Wellington Management Company
Redmile Group
William Blair Investment Management
Henderson Group
Palo Alto Investors
Deutsche Bank Aktiengesellschaft
Fiera Capital Corporation
Artal Group
Bank of America Corporation
Norges Bank Investment Management
Blackstone Group

View all funds holding Amicus Therapeutics